The Impact of Scoring Method on Accuracy and Reproducibility of Hans Cell-of-Origin Prediction in Excisional Biopsies of Diffuse Large B-Cell Lymphoma, Not Otherwise Specified.

Oleksandr Yanko, Andrew G Lytle, Pedro Farinha, Merrill Boyle, Graham W Slack, David W Scott, Jeffrey W Craig
{"title":"The Impact of Scoring Method on Accuracy and Reproducibility of Hans Cell-of-Origin Prediction in Excisional Biopsies of Diffuse Large B-Cell Lymphoma, Not Otherwise Specified.","authors":"Oleksandr Yanko, Andrew G Lytle, Pedro Farinha, Merrill Boyle, Graham W Slack, David W Scott, Jeffrey W Craig","doi":"10.5858/arpa.2024-0366-OA","DOIUrl":null,"url":null,"abstract":"<p><strong>Context.—: </strong>Aided by tissue microarray (TMA) technology, several RNA-correlated immunohistochemistry-based algorithms have been developed for cell-of-origin (COO) prediction in diffuse large B-cell lymphoma, not otherwise specified (DLBCL-NOS). However, there is currently no empirical evidence to guide the optimal application of these algorithms to whole tissue sections (WTSs).</p><p><strong>Objective.—: </strong>To assess the impact of various scoring methods on the accuracy and reproducibility of the popular Hans algorithm.</p><p><strong>Design.—: </strong>We compared 3 different WTS-based scoring methods, designated as global, selective, and hotspot scoring, to a matched TMA evaluation and gold standard RNA analysis (Lymph2Cx; germinal center B cell n = 64; activated B cell/unclassified n = 68) using a representative series of 132 excisional biopsies of de novo DLBCL-NOS. Positivity scores (10% increments) were submitted by 3 expert lymphoma pathologists, with 30% or more defining positivity.</p><p><strong>Results.—: </strong>Sixty-eight of the 132 cases of DLBCL-NOS (52%) exhibited variation in Hans immunohistochemistry marker phenotype as a consequence of scoring method and/or interscorer discordance. Although this led to changes in Hans COO assignment in 27 of 132 cases (20%), none of the WTS-based scoring methods were statistically inferior to one another in terms of raw accuracy. Hotspot scoring yielded the lowest proportion of borderline scores (20%-40% range) for BCL6 transcription repressor (BCL6) and IRF4 transcription factor (MUM1) but negatively impacted the balance between sensitivity and specificity for these markers. Selective scoring was associated with significantly worse interscorer concordance compared to TMA evaluation, which it was designed to replicate.</p><p><strong>Conclusions.—: </strong>Overall, our data favor the use of global scoring for its noninferior accuracy, solid interscorer concordance, nonnegative influence on individual Hans markers, and current widespread use.</p>","PeriodicalId":93883,"journal":{"name":"Archives of pathology & laboratory medicine","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of pathology & laboratory medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5858/arpa.2024-0366-OA","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Context.—: Aided by tissue microarray (TMA) technology, several RNA-correlated immunohistochemistry-based algorithms have been developed for cell-of-origin (COO) prediction in diffuse large B-cell lymphoma, not otherwise specified (DLBCL-NOS). However, there is currently no empirical evidence to guide the optimal application of these algorithms to whole tissue sections (WTSs).

Objective.—: To assess the impact of various scoring methods on the accuracy and reproducibility of the popular Hans algorithm.

Design.—: We compared 3 different WTS-based scoring methods, designated as global, selective, and hotspot scoring, to a matched TMA evaluation and gold standard RNA analysis (Lymph2Cx; germinal center B cell n = 64; activated B cell/unclassified n = 68) using a representative series of 132 excisional biopsies of de novo DLBCL-NOS. Positivity scores (10% increments) were submitted by 3 expert lymphoma pathologists, with 30% or more defining positivity.

Results.—: Sixty-eight of the 132 cases of DLBCL-NOS (52%) exhibited variation in Hans immunohistochemistry marker phenotype as a consequence of scoring method and/or interscorer discordance. Although this led to changes in Hans COO assignment in 27 of 132 cases (20%), none of the WTS-based scoring methods were statistically inferior to one another in terms of raw accuracy. Hotspot scoring yielded the lowest proportion of borderline scores (20%-40% range) for BCL6 transcription repressor (BCL6) and IRF4 transcription factor (MUM1) but negatively impacted the balance between sensitivity and specificity for these markers. Selective scoring was associated with significantly worse interscorer concordance compared to TMA evaluation, which it was designed to replicate.

Conclusions.—: Overall, our data favor the use of global scoring for its noninferior accuracy, solid interscorer concordance, nonnegative influence on individual Hans markers, and current widespread use.

求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信